ARTICLE | Company News
FDA approves Integrilin dosing regimen
June 11, 2001 7:00 AM UTC
Cor (CORR) and partner Schering-Plough (SGP) said the FDA approved revised prescribing information for Integrilin to include a new dosing regimen for patients undergoing percutaneous coronary interven...